Immediate Impact
59 standout
Citing Papers
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products
2025 Standout
Works of Maya Leventer‐Roberts being referenced
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population‐based study
2020
Incident gout and chronic Kidney Disease: healthcare utilization and survival
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Maya Leventer‐Roberts | 127 | 85 | 39 | 78 | 42 | 473 | |
| Denis Pouchain | 61 | 85 | 103 | 117 | 48 | 533 | |
| Sherry Pomerantz | 43 | 48 | 25 | 74 | 34 | 521 | |
| Daniel Avery | 144 | 61 | 16 | 278 | 49 | 528 | |
| McVin Hua Heng Cheen | 93 | 50 | 71 | 68 | 24 | 426 | |
| Marie Viprey | 130 | 65 | 7 | 73 | 62 | 519 | |
| Aníbal García‐Sempere | 70 | 164 | 20 | 62 | 41 | 430 | |
| Miho Kimachi | 75 | 118 | 26 | 97 | 37 | 502 | |
| Fei Xu | 100 | 114 | 48 | 147 | 49 | 537 | |
| Juan Erviti | 70 | 92 | 50 | 104 | 41 | 526 | |
| D.S. Chadha | 140 | 113 | 109 | 81 | 39 | 509 |
All Works
Login with ORCID to disown or claim papers
Loading papers...